BHP Raises Potash Project Costs, Flags $2.3 Billion Write-Down
By Rhiannon Hoyle
BHP Group said an expansion of its potash project in Canada will cost $2 billion more than expected, and that it expects to record a roughly $2.3 billion impairment charge on the development.
The world's biggest miner by market value said Thursday that it now expects to invest $6.9 billion in the second stage of the Jansen project in Canada's Saskatchewan province, up from an estimate of $4.9 billion when the project was approved in 2023.
BHP completed a review of its estimates for the expansion after reporting rising costs for the first stage of the development, which is expected to enter production next year.
The company in January raised its cost estimate for the first stage of Jansen to $8.4 billion, from an estimate of between $7.0 billion and $7.4 billion in July 2025 and an initial forecast of $5.7 billion when that project was approved in 2021.
BHP said it expects first production from the second stage of the project in late fiscal 2031.
Most of the cost increase for the expansion is from additional construction hours and materials, BHP said.
The company said the higher forecast capital intensity is likely to result in a roughly $2.3 billion write-down on the asset.
Write to Rhiannon Hoyle at rhiannon.hoyle@wsj.com
(END) Dow Jones Newswires
June 18, 2026 04:41 ET (08:41 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
